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Abstract
The identification of cardiac cells with stem cell properties changed the paradigm of the heart as a post mitotic organ. These
cells proliferate and differentiate into cardiomyocytes, endothelial and vascular smooth muscle cells, providing for cardiac
cell homeostasis and regeneration. microRNAs are master switches controlling proliferation and differentiation, in particular
regulating stem cell biology and cardiac development. Modulation of microRNAs -regulated gene expression networks
holds the potential to control cell fate and proliferation, with predictable biotechnologic and therapeutic applications. To
obtain insights into the regulatory networks active in cardiac stem cells, we characterized the expression profile of 95
microRNAs with reported functions in stem cell and tissue differentiation in mouse cardiac stem cells, and compared it to
that of mouse embryonic heart and mesenchymal stem cells. The most highly expressed microRNAs identified in cardiac
stem cells are known to target key genes involved in the control of cell proliferation and adhesion, vascular function and
cardiomyocyte differentiation. We report a subset of differentially expressed microRNAs that are proposed to act as
regulators of differentiation and proliferation of adult cardiac stem cells, providing novel insights into active gene
expression networks regulating their biological properties.
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Introduction
The observation of cardiomyocyte division first questioned the
paradigm that the mammalian heart is a post-mitotic organ. The
isolation of adult heart cells expressing markers of stemness (c-kit,
Sca-1 or MDR1) displaying the fundamental properties of stem
cells: self-renewal, clonogenicity, and multipotency [1] further
challenged this paradigm.
It is estimated that approximately 36106 cells are generated in
the human heart every day, arising from the multiplication of
cardiac stem cells (CSCs) [2]. In terms of phenotype, CSCs are
undifferentiated, keep quiescent until induced to proliferate and
may differentiate into one of the three cardiac cell lineages:
cardiomyocytes, endothelial cells and vascular smooth muscle
cells.
The origin of the CSC population remains unclear. They are
either believed to be the progeny of mesenchymal cells from the
bone marrow, which homed to the heart through systemic
circulation, or to correspond to cellular remnants of the embryonic
heart [3]. During embryogenesis, a tightly orchestrated gene
expression program involving cardiac specific genes and tran-
scription factors that are activated in succession is initiated,
coordinating heart development, along with the differentiation of
the main cardiac cell lineages [4]. Interestingly, genes that control
cardiac formation during development are active in CSCs.
Furthermore, during the differentiation process from CSCs to
cardiomyocytes, CSCs seem to replicate the embryonic program
[5–7]. However, unlike embryological cells developing into
cardiomyocytes, for which once the process begins it inexorably
leads to the final phenotype, the adult CSC manages to become
stuck in an intermediate stage; both the mechanisms that stop and
restart CSCs are unknown.
In the last decade microRNAs (miRs) have been found to play
important roles in the regulation of multiple biologic functions,
including the control of stem cell and tissue differentiation [5,8–
11], response to stress and in particular, heart development and
disease [12–16]. There are approximately a thousand miRs in the
human genome, each one targeting multiple RNAs and exerting
an influence on their turnover and translation to different degrees,
depending on the specific characteristics of the miR-mRNA
interaction [17]. As a consequence of these multiple interactions,
miRs create complex gene regulatory networks that can serve
multiple purposes, from lending robustness to cellular responses, to
acting as developmental switches or broad enforcers of tissue and
cellular identity [18–20]. Therefore, the miR expression profile of
a given cell type emerges as a bona fide marker of the active
regulatory networks that define the cell’s biological characteristics.
The identification of the CSC miR expression profile and of
their role in CSC biology has never been systematically addressed.
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We report the first partial miR expression profile of CSCs isolated
from adult mouse hearts, focusing on a subset of miRs known to be
involved in the regulation of stem cell and tissue differentiation
processes. Comparative analysis with embryonic heart cells from
day E9 and immature c-kit positive bone marrow progenitor cells
(BMCs) has allowed us to identify a differential expression profile
that correlates strongly with the biological properties of this adult
stem cell population, providing novel insights into cell identity and
phenotype.
Methods
CSC Isolation
a) Cardiac cell suspension. Balb/c mice were sacrificed by
euthanasia with CO2 asphyxiation and the hearts were removed
and washed by injecting 1 ml of Hank’s Balanced Salt Solution
(HBSS) without Ca2+ e Mg+ (Sigma-Aldrich). The hearts were
sliced into small clumps (,1 mm3) in a microtube with 500 ul of
F12- Kaighn’s Media (F12-K) (GIBCO #21127) supplemented
with 10% Fetal Bovine Serum (FBS - GIBCO), 3% Penicillin/
Streptomycin (GIBCO #15140-122) e 1% Transferrin Sodium
Selenite (ITSS) (Sigma-Aldrich # 1884) (F12-K+) and incubated
at 37uC for 20 minutes with agitation (140 rpm). The tissue
suspension was filtered through a 40 mm nylon mesh at least three
times in order to exclude the larger cardiomyocytes from the heart
tissue. The cell suspension was centrifuged at 12000 rpm for 10
minutes at 4uC and then the pellet was resuspended in 1 ml of
FACS buffer (HBSS and 5% FBS).
b) Fluorescent activated cell sorting. Cardiac cells were
then labeled with monoclonal antibody, anti-Sca1 (d Mouse LY-
6A/E, clone E13–161.7 Rat IgG2a – BD
PharmingenTM#553355) conjugated with Fluorescein isothiocya-
nate (FITC). Staining was done at 4uC in the dark for 30 minutes
and washed with FACS buffer. Cells resulting from this procedure
were sorted by FACS in a FACS Aria high-speed cell sorter
(Becton Dickinson, San Jose´, CA, USA) with a 70 mm nozzle
at.5 MPa (70 psi). A 488 nm (15 mW output) coherent Sapphire
solid state laser was used to excite FITC. Fluorescein emission was
detected with a 530/30 band-pass filter. Sca-1-FITC positive cells
were collected directly into an RNA later solution (RNAlaterH
solution #AM7020-Ambion) and stored at 220uC. Both sample
and collection tubes were kept at 4uC throughout sorting.
Bone Marrow Stem Cell Isolation
a) Bone marrow suspension. Isolation of bone marrow
lineage negative cells was performed as follows: Balb/c mice were
sacrificed by euthanasia with CO2 asphyxiation. The femur and
tibia were removed and the bone marrow was collected by flushing
with FACS buffer (HBSS and 5% FBS). The cell suspension was
filtered through a 40 mm nylon mesh and centrifuged at
12000 rpm for 3 minutes at 4uC. Cells were washed once with
FACS buffer and the cell pellet was resuspended with 1 ml FACS
buffer.
b) Fluorescent activated cell sorting. For Fluorescent
Activated Cell Sorting, samples were treated with FcBlock (d
Mouse CD16/32, clone 2.4G2 Rat IgG2b - IGC) for 15 minutes,
at 4uC and washed once, stained with an antibody cocktail : B220-
Bio (d Mouse CD45R, clone RA3 6B2 Rat IgG2b - IGC), Mac1-
Bio (dMouse CD11b, clone M1/70 Rat IgG2b – BD Pharmingen
TM#553309), TER-Bio(d Mouse TER 119/Erythroid cells, clone
TER 119 Rat IgG2b – BD Pharmingen TM#553672), GR1-Bio
APC (d Mouse Ly-6G/Ly-6C, clone RB6-8C5 Rat IgG2b – BD
PharmingenTM#553125), CD5-PE (d Mouse CD5, clone 53-7.3
Rat IgG2a – BD PharmingenTM#553023), c-kit-APC APC (d
Mouse CD117, clone 2B8 Rat IgG2b – BD
PharmingenTM#553355) for 20 minutes, at 4uC, in the dark
and washed twice with FACS buffer. The last staining was done
with SAV-PE (d Mouse Streptavidin-Phyerythrin, clone Strepta-
vidin – BD PharmingenTM#554061) for 20 minutes, at 4uC, in the
dark and the cells were washed twice with FACS buffer. Cells
resulting from this procedure were sorted by FACS in a BD FACS
Aria high-speed cell sorter as above. PE was excited with the
488 nm line, and a 633 nm (18 mW output) JDS Uniphase HeNe
air-cooled laser was used for APC excitation. PE and APC
emissions were detected using a 585/42 nm and a 660/30 nm
band-pass filters, respectively. Cells expressing c-kit (APC positive)
and negative for lineage markers (PE negative) were sorted and
collected directly into an RNA later solution (RNAlaterH solution
#AM7020-Ambion) and stored at 220uC. Both sample and
collection tubes were kept at 4uC throughout sorting.
Isolation of Embryonic Heart Cells
For the isolation mouse embryonic hearts cells Balb/c mice
were used for embryo collection. Females were sacrificed by
cervical dislocation nine days after mating to harvest embryos at
the desired stage – E9. Embryos were dissected in PBS buffer and
hearts were collected, including the first and second heart field,
transferred to RNA later solution (RNAlaterH #AM7020-
Ambion) and stored at 280uC. RNA extraction and quality
control was performed as described.
RNA Isolation
Total RNA isolation from samples (including miR fraction) was
performed with the mirVana miR Isolation Kit (Ambion -
#AM1561), following the manufacturer’s instructions. Samples
were characterized in the Lab-on-a-chip 2100 Bioanalyzer
(Agilent) using the pico6000 RNA chip for quantification and
quality control of RNA preservation.
miR Profiling
The Stem Cell miR qPCR Array with QuantiMir TM (System
Biosciences #RA 620A-1) was used to quantify miRs present in
the different cell populations by quantitative real-time PCR
according to the manufacturer’s instructions on a CFX Real Time
System c1000 Thermal Cycler (BioRad) real-time qPCR instru-
ment.
TaqMan miR Assays (Applied Biosystems) were used for
quantification of specific miRs and the control housekeeping
RNA sno202 using 1 ng of total RNA input as indicated by the
manufacturer.
mRNA Expression Analysis
Removal of genomic DNA from RNA samples was carried out
using DNase I (Fermantas). Reverse transcription was done using
the RevertAidTM H Minus First Strand cDNA Synthesis Kit
(Fermentas) with 1 ug of RNA and oligo dT priming according to
the manufacturer’s instructions.
The PCR amplification of the cDNA products was performed
with the DreamTaqTM DNA Polymerase (Fermentas). The
following primers were used for RT-PCR analysis: GAPD -
Forward primer: TGCACCACCAACTGCTTAGC; Reverse
primer: GGCATGGACTGTGGTCATGAG; c-Myc - Forward
primer: TGAGCCCCTAGTGCTGCAT; Reverse primer:
AGCCCGACTCCGACCTCTT; Isl1 - Forward primer: TATC-
CAGGGGATGACAGGAA; Reverse primer: TTGAC-
CAGTTGCTGAAAAGC.
microRNA Regulation of Cardiac Stem Cells
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Data Analysis
Analysis of qPCR array data was performed as follows: raw Ct
values were normalized by the quantile method using HTqPCR
package (Dvinge and Bertone, 2009) implemented in Bioconduc-
tor (Gentleman et al. 2004). The quantile method produces a
uniform empirical distribution of Ct values across samples,
allowing for direct comparison of Ct values, and is especially
useful when housekeeping genes show significant variation across
samples, as was the case in this study. miRs which were outside the
90% CI were considered unreliable and miRs which had a Ct.38
for more than 3 libraries were considered undetermined and were
not considered for further analysis. miRs with relatively constant
Ct levels are less likely to be differentially expressed, so including
them in the downstream analysis would cause some loss of power
when adjusting the p-values for multiple testing (the miR-by-miR
hypothesis testing). Variation across samples was assessed using the
interquantile range values (IQR) for each miR. All miRs with an
IQR below 1.5 were filtered out.
Clustering analysis was performed by estimating the euclidean
distance between samples using gplots package of R (http://cran.
r-project.org/web/packages/gplots/index.html).
Analysis of differential expression was performed using the lmfit
function of the Limma package of Bioconductor (Smyth, 2004).
The Limma package applies a linear model to the expression data
for each gene and tests for significant differences using a
moderated t-test based on an empirical Bayes method to moderate
the standard errors of the estimated log-fold changes. This results
in more stable inference and improved power, especially for
experiments with small numbers of replicates. p values were
adjusted with the Benjamini-Hochberg algorithm to control for
false discovery rate. microRNAs with an adjusted p value,0.01%
were considered to be differentially expressed.
Ethics Statement
All animal work was performed according to Portuguese laws
and European Union Directives. Mice were exclusively used for
collection of sample tissues after being sacrificed according to
standard procedures.
Results
The miR Expression Profile of Adult Mouse CSCs Reveals
Commitment to Cardiac Lineages
The characterization of the miR expression profile of a specific
cell type is expected to provide relevant insights into the regulatory
networks that define its biological properties. However, profiling
transcript levels from rare cell populations with low total RNA
levels can represent a technical challenge. CSC isolation has been
reported by several laboratories worldwide, using protocols that
include tissue digestion and Fluorescence Activated Cell Sorting
(FACS) with stem cell membrane markers as c-kit, Sca-1 or
MDR1 [2,21,22]. However, previous studies on CSC gene
expression have focused either on embryonic cells [23] or on fetal
cells after proliferation in culture [24].
To obtain high quality total RNA samples in order to
characterize the adult CSC miR expression profile, we developed
a method to isolated cells from mice hearts by soft mechanical
destruction of cardiac tissue, followed by Sca-1 antigen labeling
and FACS sorting (Figure S1). Cells isolated through this approach
could be grown in culture and induced to proliferate or
differentiate into spontaneously beating cardiomyocytes, as
expected from bona fide cardiac progenitors (data not shown). As
control, we isolated bone marrow c-kit+ lineage- BMCs from the
same mice. Quantifiable amounts of high quality total RNA could
be obtained from sorted 105 BMCs, while total RNA from 46105
CSCs remained below detection limits (50 pg/ml). However, using
RT-qPCR we could consistently detect the expression of the
housekeeping sRNA sno202 (not shown).
The abundance of total RNA is known to vary widely across
tissues and, in particular, between proliferating and quiescent cells
[25]. The low levels of total RNA in CSCs impose significant
restrictions to large scale profiling studies without the use of bias-
prone pre-amplification steps. However, highly sensitive, qPCR
based approaches may be applied under such conditions. We
therefore generated a focused profile of the expression of 95 miRs
involved in stem cell maintenance and differentiation processes in
mouse CSCs using a commercial RT-qPCR array (see Table S1)
from three independent samples. Data from these samples showed
a good correlation after normalization, with one third of the miRs
analyzed being below detection limit. The most abundant miRs
detected - Table 1 – are all known to have strong functional
correlations to cardiovascular development and disease. In line
with the known potential of CSC to give rise to distinct cardiac
lineages, the most abundantly expressed miRs found in these cells
are considered specific of cardiomyocyte, endothelial and vascular
smooth muscle cells, revealing possible regulatory mechanisms
that underlie the CSC differentiation ability.
Comparative Profiling of CSC, Embryonic Heart Cells and
Adult BMCs Reveals a Cardiac Stem Cell Specific
Signature
In order to further identify key miRs regulating CSC biology,
we performed a comparative approach with two populations of
multipotent progenitors that may give rise to cardiac cell lineages
and eventually represent the precursors of stem cells isolated from
the adult heart: immature bone marrow cells (BMCs; c-kit+,
hematopoyetic lineage negative) and embryonic heart cells from
day E9.
The comparison between these populations is expected to reveal
some underlying differences regarding the activation of gene
expression programs related to stem cell maintenance, prolifera-
tion and cardiac lineage commitment, providing important
insights into the origins and biology of adult cardiac stem cells.
Total RNA samples isolated from three independent replicates
of mouse BMCs and E9 embryonic hearts were used for miR
profiling with the Stem Cell miR q-PCR array (see Table S1). To
obtain an overview of the similarities and differences of their miR
expression profile relative to CSCs, we performed an unsupervised
clustering analysis of our expression datasets for both sample and
miR, after normalizing miR Ct values across samples with the
quantile method and filtering out miRs with low variation across
all samples (Fig. 1).
The biological replicates of each cell type clustered together,
demonstrating the robustness of this dataset. Surprisingly, CSCs
segregated independently from both BMCs and embryonic heart
samples, which are grouped in a common branch. Analysis of the
clustering profile suggested that this was mainly determined by a
group of nine miRs that is highly expressed in these two cell
populations and absent from CSCs (Fig. 1A, inset). Eight of these
miRs belong to the miR-17-92 cluster family, encoded in three
related genomic loci (Fig. 1B). The miR-17-92 cluster family is
highly expressed in proliferating cells and has been shown to have
oncogenic potential [23,26,27]. Additionally, they have been
shown to be required for normal heart development [28–30] and,
more interestingly, to control the differentiation of cardiac
progenitors [6,28,31].
microRNA Regulation of Cardiac Stem Cells
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CSCs Differentially Express Key Regulators of Cardiac and
Vascular Development
The clustering analysis presented above (Fig. 1) additionally
reveals groups of miRs that distinguish CSCs from both BMCs
and embryonic heart cells. In order to understand how CSCs
differ from BMCs we performed a differential expression analysis
between the two samples and identified ten differentially expressed
miRs (adjusted p value,0.01), six of which are up-regulated in
CSCs (Fig. 2A). As expected, three members of the miR-17-92
family already identified in the clustering analysis were found to be
significantly down-regulated in CSCs, together with miR-223, a
well-known regulator of hematopoietic differentiation [32–34].
Among the six up-regulated miRs in CSCs we find the four most
highly expressed miRs in these cells: miR-125b, miR 126, miR-
133a and miR-24. miR-133a emerged as the most differentially
expressed between the two cell types, with an 100 fold higher
expression level in CSCs, followed by a member of the same miR
family, miR-133b. These muscle-specific miRs are key regulators
of the cardiomyocyte differentiation process and have been shown
to control the expression of cardiomyocyte specific proteins
(reviewed by [13,35,36]). The other three miRs also have been
linked to cardiac functions (see discussion). Additionally, miR-218
also displays a significant enrichment in CSCs when compared to
BMCs. miR-218 was recently shown to function in vascular
development [37–39] and to be required for heart tube formation
[28,39,40]. This CSC miR expression profile implies that CSCs
already display a significant degree of commitment to cardiac
lineages. To further explore this aspect and discard the possibility
of eventual contamination of our samples with differentiated
cardiomyocytes, we independently determined the expression
levels of miR-1, a hallmark of cardiomyocyte differentiation, and
two additional miRs known to be essential for muscle differenti-
ation processes: miR-208a and miR-206. miR-208a is encoded in
an intron of the myosin heavy chain gene Myh6 [41,42] and is
part of a family of so-called ‘myomirs’, named after their
important roles in muscle differentiation. miR-206 is another
member of the miR-1/133 family that exhibits skeletal muscle
specific expression. For this purpose, we used commercially
available Taqman based RT-qPCR probes, and compared their
expression levels in mouse heart tissue. As a control, we quantified
the expression of the abundant and ubiquitously expressed miR-
21. This analysis confirmed our previous observation that miR-1
cannot be detected in adult CSCs or in embryonic heart cells at
day E9, although it is highly expressed in mouse heart tissue
(Figure 2B). In contrast, the expression levels of mir-208a are very
similar in both cell types and heart tissue, albeit undetectable in
BMCs, confirming the commitment of CSCs to the cardiomyocyte
lineage. Interestingly, this is in agreement with the identification of
cardiac myosin heavy chain-alfa in a proteomic profiling of CSCs
(Bra´s-Rosa´rio, unpublished data). As expected, miR-206 could not
be detected in any of the samples tested. These results confirm that
CSCs already display a significant degree of commitment to
cardiac lineages, displaying a miR expression profile that is more
similar to embryonic cardiac progenitors.
Overexpression of Anti-proliferative miRs Distinguishes
Cardiac Stem Cells from Embryo Heart Cells
In order to better understand the similarities and differences
between CSCs and embryonic heart cells, we performed a
differential expression analysis between the two datasets and
found a total of thirteen miRs with either significant up-
regulation (seven miRs) or down-regulation (six miRs) (adjusted p
value,0.01) (Figure 2C). Similar to what was observed when
comparing cardiac and immature bone marrow SCs, four of the
six down-regulated miRs belong to the miR-17,92 cluster
family, corresponding to some of the most highly expressed miRs
in embryonic heart cells.
Of the other two down-regulated miRs in CSCs, miR-302d has
been described as embryonic stem cell specific in both mouse and
humans [43,44], whereas miR-107 belongs to the miR-15/107
family. In mouse this family includes 11 miRs that share the seed
sequence AGCAGCA and are encoded by independent genes
[5,21,45]. The miR-15/107 family has been shown to co-regulate
several mRNA targets that encode key proteins for distinct cellular
functions, including metabolic regulation, cell cycle control,
control of metastasis and epithelial mesenchymal transition and
stem cell plasticity [5]. To understand if the observed down-
regulation of miR-107 may reflect a CSC specific fine-tuning of
the pathways regulated by this group of miRs, we looked for the
presence of other members of the miR-15/107 family in our
dataset. Four miRs, representing the most highly expressed
members of this family (miR-16, miR 103 and miR-195), were
present in the array used in our study. Strikingly, they all show
similar expression levels in embryonic heart, BMCs and CSCs,
with the exception of miR-107 (Figure 2D). Thus, down regulation
of miR-107 seems to be a distinctive feature of CSCs, implying a
CSC specific regulatory profile for miR-15/107 target genes. The
implications of this are presently unclear, as miR-107 seems to
Table 1. Top 10% expressed miRs in adult CSCs.
miR Av expr (Ct) Reported function Reference
miR-125b 28.660.2 Involved in cardiac stress response. [48]
miR-126 29.261.0 Regulator of endothelial lineage and angiogenesis in cardiovascular development. Involved
in cardiac disease and adult cardiomyocyte hypertrophy.
[49]
miR-133a 29.460.6 Regulation of cardiomyocyte differentiation. Promotion of undifferentiated progenitor expansion.
Involved in cardiac disease and adult cardiomyocyte hypertrophy.
[49]
miR-23a 29.760.3 Response to cardiac injury. [48]
miR-24 29.960.8 Response to cardiac injury. [48]
miR-23b 30.160.4 Response to cardiac injury. [48]
miR-125a 30.1+0.5 Response to cardiac injury. [48]
miR-30c 30.1+0.3 Involved in cardiac disease and adult cardiomyocyte hypertrophy. [49]
miR-132 30.3+0.8 Regulators of endothelial lineage and angiogenesis in cardiovascular development. [31]
doi:10.1371/journal.pone.0063041.t001
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share almost 80% of its targets with both miR-16 and miR-103
and there are contradictory reports regarding its role, for example,
in cell cycle control [5,9]. Interestingly, this family of miRs was
recently linked to the control of the post-natal mitotic arrest of
cardiomyocytes [12], which seems to involve the up-regulation of
several miR-15 family members, while miR-107 becomes down-
Figure 1. Comparative miR expression in progenitor cell populations with cardiogenic potential. A. Hierarchical clustering for samples
and miRs of three independent replicates of mouse CSCs (CSC), adult BMCs isolated from mouse bone marrow (BM) and mouse embryonic heart day
E9 (EMB). Box highlights the miR branch separating CSCs from BMCs and embryonic heart cells, composed almost exclusively of miR-17/92 family
members. Data shown refers to normalized Ct values (color key) of filtered subset of 41 differentially expressed miRs, out of the 95 miRs analyzed (see
methods). B. The mouse miR-17/92 family loci. Expression levels for all members of this cluster were determined, with the exception of miR-363,
which was not present in the PCR array used in this study.
doi:10.1371/journal.pone.0063041.g001
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regulated. These results point to a possible link between the
expression of this miR and the maintenance of a quiescent state in
CSCs.
In addition to this group of down-regulated miRs, CSCs can be
distinguished from embryonic heart cells on the basis of seven up-
regulated miRs: let-7a, let-7b, miR-24, miR-125b, miR-132, miR-
149 and miR-223 (Fig. 2C).
As mentioned above, miR-24, miR-125b and miR-132 are
among the top expressed miRs in CSCs. In contrast, we observed
that miR-223 is down regulated in CSCs in comparison to BMCs,
in agreement with its established role as a regulator of
hematopoyesis. Little is known regarding the function of miR-
149, in addition to the fact that it has been identified as being
down regulated in response to cardiac injury [18].
The let-7 miRs belong to a conserved family of genes known to
be involved in the control of stem cell proliferation and
differentiation [21], acting as tumor suppressors. Interestingly,
let-7a targets the oncogenic transcriptions factors Ras and Myc
and is negatively regulated by the latter. Thus, high levels of let-
7a/b expression are in agreement with the non-proliferating
phenotype of CSCs, which seem to have several Myc-dependent
expression networks silenced. miR-24 is also a known anti-
Figure 2. Differential expression analysis of microRNAs. A. Differentially expressed miRs in adult cardiac and immature bone marrow stem
cell populations (CSCs and BMCs). Average log2 expression ratio of all differentially expressed miRs (p,0.01). B. Comparison of expression of muscle
specific miRs in embryonic heart cells (EMB), BMCs and CSCs, and mouse heart tissue using Taqman probes (n = 3). Data shows relative expression
(22DCt) normalized to sno202 RNA expression levels. C. Differentially expressed miRs in adult cardiac versus embryonic mouse heart cells. Average
log2 expression ratio of all differentially expressed miRs (p,0.01). D. miR-15/107 family expression levels in the cell populations characterized in this
study. Plot displays normalized Ct values for each independent biological replicate sample of miR-15/107 family members present in the qPCR array.
miR-107 is specifically downregulated in CSCs. Horizontal bar marks average Ct.
doi:10.1371/journal.pone.0063041.g002
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proliferative miR that acts as a negative regulator of Myc
expression [26].
Silencing of myc-dependent Pathways in CSCs
The comparison of miRs expressed in CSCs and embryonic
cardiac progenitors suggests that these cell populations differ in the
activation of Myc dependent pathways. Thus, CSCs over-express
miR-24 and the let-7a/b miRs, which are known to negatively
regulate Myc expression, while showing a very strong down-
regulation of the miR-17/92 family, which is a known transcrip-
tional target of Myc. Interestingly, this miR family was recently
shown to be required for the terminal commitment of embryonic
cardiac progenitor cells from the secondary heart field to
cardiomyocyte differentiation [28]. This involves the direct
targeting of the mRNA encoding the LIM-homeodomain tran-
scription factor Islet1 (Isl1), a marker of pluripotent undifferenti-
ated cardiovascular progenitors, which has been proposed to act as
an anti-differentiation factor. Together with our miR profiling
data, these observations led us to propose a network of
transcriptional interactions that could underlie the CSC pheno-
type (Fig. 3A). We therefore decided to look at the expression of c-
Myc and Isl1 in our Sca1+ CSC populations and compared it to
embryonic cardiac progenitors and total heart tissue (Fig. 3B).
Interestingly, we find that, as predicted, c-myc expression is
silenced in CSCs whereas Isl1 expression can be detected at
relatively high levels when compared to embryonic progenitor
cells. Our results suggest that Isl1 may indeed represent a common
marker of cardiac progenitor cells, and that the activation of the
miR-17-92 cluster may act as a general orchestrator of cardiac
progenitor differentiation.
Discussion
In this study we present a focused profiling of the expression of
stemness and differentiation related miRs in Sca1 positive adult
CSCs. Our results provide new insights into active regulatory
networks underlying the control of proliferation and differentia-
tion, two critical aspects of CSC biology.
In spite of the its importance for the understanding of regulatory
mechanisms controlling CSC function, the characterization of
transcript abundance in this cell population is complicated by
three factors: the rarity of these cells (less that 2% of the total heart
cells [6]); the difficulty of isolating good quality samples from
fibrous heart tissues, and the comparatively low levels of total
mRNA present in these cells. Indeed, while we where easily able to
quantify and evaluate the quality of total RNA isolated from 105
Sca1+ BMCs isolated from the bonemarrow (Fig. S1), total RNA
obtained from four times as much Sca1+ CSCs remained below
detection limits (i.e, 50 pg/ml using the Agilent RNA 6000 Pico
Kit), in spite of significant improvements in purification proce-
dures. This imposes significant restrictions to the application of
large scale profiling studies, while allowing for the use of focused,
highly sensitive, qPCR based miR-profiling approaches.
The consistent identification of miRs that are considered
specific of the three cell lineages that CSCs can differentiate into
- cardiomyocyte, endothelial and vascular smooth muscle cells
([32], see discussion below) - underscores the robustness of our
isolation procedure. Of note, endothelial pericytes may also
express Sca-1 [35]. However, the degree of enrichment in
cardiomyocyte specific miRs that we observed makes it unlikely
that a significant amount of these cells may be present in our
samples. The fact that we could not detect expression of the
cardiomyocyte-specific miR-1 in CSC samples using two inde-
pendent methods, while we confirmed it to be highly expressed in
total heart tissue, further demonstrates the absence of significant
contamination from other cardiac cell types. Therefore our
profiling study specifically reflects the miR-regulatory networks
underlying CSC function and cell fate decision.
The comparison of CSC miR expression profile with that of
BMCs and embryonic heart cells, which display similar differen-
tiation potential and have both been hypothesized to correspond
to the CSC progenitor population [37], gives unprecedented
information on the possible miR regulated pathways involved in
establishing the CSC phenotype. Interestingly, silencing of the
miR-17/92 cluster emerges as the major difference between CSCs
and their two potential progenitor populations. In heart develop-
ment, this cluster is activated by BMP signaling to downregulate
the cardiac progenitor genes Isl1 and Tbx1 and promote cardiac
differentiation in a feed forward mechanism [28]. Therefore, the
miR-17-92 cluster seems to play an essential role in controlling the
timing and differentiation potential of Isl-1 positive cardiac
progenitor cells, which represent a common multipotent progen-
itor lineage present both in the embryonic and adult heart, with
the ability to generate both cardiomyocyte, endothelial, and
VSMC descendents [4,46,47].
The miR-17-92 cluster is known to be regulated by c-myc
leading us to hypothesize that the expression of this transcription
factor is down-regulated in CSCs. In agreement with this model,
we were unable to detect c-myc transcrips in CSCs, in contrast
with what was observed in samples from adult and embryonic
heart. In parallel with the down-regulation of this gene, and in
contrast with previous studies [6,7], we detected a significant
expression of the Isl1 transcription factor. This discrepancy may
be explained by a higher quality of the CSCs RNA samples used in
the present study, and suggests that Isl1 may indeed represent a
common marker of all cardiac progenitors, ending a long-term
unexplained discrepancy regarding Sca1+ cells [8,10,11].
In addition to the down-regulation of the miR-17-92 cluster, the
differential expression analysis of CSCs in comparison with BMCs
and embryonic cardiac cells identified the over-expression of
several miRs involved in the control of cellular differentiation
processes. The expression of miR-133a, miR-133b and miR-208 is
considered a specific mark of cardiomyocyte lineage differentiation
[13–16]. In this study, we have found that these miRs are highly
expressed in CSCs, while expression of miR-1, the other
cardiomyocyte specific miR, could not be detected. The muscle
specific miR-1 and miR-133a are encoded in the same bicistronic
transcriptional unit, under the control of the cardiogenic
transcription factors MEF2 and SRF [19,20]. Both miRs have
been shown to be involved in the control of the expression of
cardiac specific proteins [2,22]. Additionally, miR-1 and miR-
133a are key regulators of cardiomyocyte proliferation and
differentiation, assuming antagonistic roles in these processes.
Indeed, while miR-1 promotes differentiation of ES cells towards a
cardiac fate, miR-133 inhibits differentiation into cardiac muscle
[23,27]. The differential expression of miR-133 in CSCs is
therefore clearly indicative of a commitment to the cardiomyocyte
lineage, compatible with the maintenance of an undifferentiated,
non-proliferative state. The parallel identification of miR-208
expression, an intronic miR encoded in the cardiac alfa-myosin
heavy chain (aMHC) gene, which promotes the transition from
the embryonic to adult isoforms of cardiac contractile proteins,
further stresses the CSC commitment to the adult cardiomyocyte
lineage. Balancing the CSC commitment to the cardiomyocyte
lineage is the identification of a significant overexpression of miR-
126, considered the only miR characteristic of endothelial cells
[29,30]. Some of the other miRs identified as highly expressed in
CSCs have also been specifically implicated in endothelial cell
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development and regulation. In particular, miR-132 is an inducer
of endothelial cell differentiation and proliferation, pointing to the
commitment of CSCs to this lineage [28,31]. In addition to the
above mentioned role as a regulator of endothelial differentiation,
miR-132 was recently shown to regulate the expression of the b2
subunit of the cardiac L-type calcium channel protein [33,34] and
to function as a paracrine activator of heart healing [13,36]. miR-
23b is involved in the mechano-transduction of proliferative
signals in endothelial cells [38,39], whereas miR-218 was recently
shown to be a critical regulator of vasculogenesis and heart tube
formation during development [39,40]. One should also remark
that both miR-126 and miR-218 interact with the VEGF pathway,
raising the hypothesis that VEGF is involved in CSCs differen-
tiation into endothelial cells. Finally, CSCs are also known to
differentiate into a third lineage, vascular smooth muscle cells
(VSMCs). VSBMCs display an unusual ability to switch between a
proliferative and differentiated (contractile) phenotype ant it was
recently shown that miR-24 is involved in the regulation of this
process, promoting VSMC dedifferentiation [41,42]. Additionally,
miR-24 was shown to suppress cardiomyocyte apoptosis [43,44].
These results suggest that CSCs display a significant degree of
commitment to differentiation into the three main cardiac lineages
- cardiomyocyte, endothelial and vascular smooth muscle cells -
and provide evidence for the presence of miR-dependent
regulatory networks defining an overall cardiac-committed yet
undifferentiated phenotype.
An adult stem cell population needs to maintain its numbers,
control the balance between cell division and the number of cells
that undergo differentiation into diverse cell lineages. Comparative
profiling of CSCs and embryonic heart cells identified the let-
7 miR family members, let-7a, let-7b, miR-125a and miR-125b,
as well as miR-223 as being upregulated in CSCs. Additionally,
another member of the let-7 family, miR-125a, was found to be
highly expressed in CSCs. These miRs have reported roles as
regulators of stem cell proliferation, apoptosis and differentiation,
and are likely to contribute to the maintenance of a non-
proliferative and undifferentiated state, albeit with limited
potential [5,21,45].
All together, the miR expression profile of CSC conveys a
picture of tight control of proliferation and cell fate orientation
with three cardiac lineages – cardiomyocyte, endothelial cell and
vascular smooth muscle – in accordance with previous known
biological activities of CSCs, reinforcing the possible role of miRs
in their control. A major question that remains to be answered is
whether the Sca-1 positive cells characterized in this study
represent a homogenous population where these regulatory
networks are all active, or whether specific subtypes within this
population differentially over-express markers of each lineage and
therefore display a more defined commitment state than what may
be inferred from the analysis of the whole population. Future
studies will help address this question and explore the role of
specific miRs identified in this work in the control of CSC
function.
Figure 3. Expression of myc and Isl1 in CSCs. A. Proposed regulatory network involving differentially expressed miRs in embryonic heart (EMB)
and CSCs. B. Expression of c-Myc and Isl1 in embryonic heart and CSCs by semi-quantitative RT-PCR. Results are representative of three independent
replicate samples. C. Quantification of relative expression levels of c-Myc and Isl1 (n = 3). Expression levels are normalized to GAPDH.
doi:10.1371/journal.pone.0063041.g003
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Supporting Information
Figure S1 Fluorescence activated cell sorting of Sca-1
expressing cells isolated from adult mouse heart. An
unstained sample (left plot, A) was used as negative control to
define the sorting gate. Sca-1 positive cells (right plot, A) were
identified based on FITC-positive signal in the 530/30 nm
channel, and distinguished from negative cells with high
autofluorescence using an autofluorescence channel with
585620 nm range.
(TIF)
Table S1 Raw and normalized qPCR data for miR expression
profiles in mouse adult cardiac stem cells (CSC), bonemarrow lin
negative, c-kit positive immature bone marrow stem cells (BM) and
mouse embryonic heart (EMB). Excel file, two worksheets.
(XLS)
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